Dr. Saw Discusses Study of Vitamin D in Melanoma

Robyn Saw, FRACS, MS, MBBS
Published Online: Monday, Oct 30, 2017



Robyn Saw, FRACS, MS, MBBS, associate professor of surgery, The University of Sydney, discusses a study of vitamin D in melanoma.

This phase II study aims to find an alternative therapy option for patients with melanoma who are at high risk for recurrence. Currently, the only option for these patients is surgery.

In the study, patients received adjuvant therapy with high-dose vitamin D following primary treatment. Vitamin D has shown potential to delay recurrence and improve prognosis. Currently, there is no effective nontoxic adjuvant therapy for this population.
 


Robyn Saw, FRACS, MS, MBBS, associate professor of surgery, The University of Sydney, discusses a study of vitamin D in melanoma.

This phase II study aims to find an alternative therapy option for patients with melanoma who are at high risk for recurrence. Currently, the only option for these patients is surgery.

In the study, patients received adjuvant therapy with high-dose vitamin D following primary treatment. Vitamin D has shown potential to delay recurrence and improve prognosis. Currently, there is no effective nontoxic adjuvant therapy for this population.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Community Practice Connections™: 13th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®Apr 28, 20182.0
Publication Bottom Border
Border Publication
x